A new policy brief from Health Affairs and the Robert Wood Johnson Foundation (RWJF) describes the repercussions of antibiotic resistance: when drugs have declining, limited, or no effectiveness in combatting certain bacterial infections. In the United...
Filed under: Public Health, Global Health, Elsewhere@ Health Affairs, Population Health, Drugs and Medical Technology, FDA, Antimicrobial, Antibiotic Resistance, Agriculture, Research and Development, superbugs, Drug approval